Skip to main navigation Skip to search Skip to main content

Vitamin D for Painful Diabetic Neuropathy: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials

Research output: Contribution to journalReview article (Academic Journal)peer-review

3 Citations (Scopus)

Abstract

Background
Painful diabetic neuropathy (PDN) is a common complication of type 1 and type 2 diabetes, causing substantial morbidity. Current treatments, including antidepressants and analgesics, are often only partially effective and may have significant side effects. Vitamin D deficiency affects around 60% of people with diabetes, making supplementation a low-toxicity, biologically plausible intervention. Observational studies suggest potential benefit, but robust evidence from randomised controlled trials (RCTs) is lacking.

Objective
To systematically review and synthesise RCT evidence on the effect of vitamin D supplementation on pain outcomes in PDN.

Methods
A systematic search was conducted in Medline, EMBASE, Web of Science, Cochrane Library, CINAHL, EBSCO and Google Scholar up to September 2025. Eligible studies were RCTs comparing vitamin D supplementation with placebo in adults with diabetes and PDN. The primary outcome was pain intensity measured with validated tools. A fixed-effects meta-analysis was performed, with results expressed as standardised mean differences (SMD). Risk of bias was assessed using the Cochrane RoB tool, and publication bias examined via Egger's funnel plot.

Results
Five studies met inclusion criteria; four (n = 320) were included in the meta-analysis. Pooled results showed a significant short-term reduction in pain with vitamin D versus placebo (SMD = −0.85; 95% CI: −1.07 to −0.62), with moderate heterogeneity (I2 = 61.4%), equivalent to ~11 points on common pain scales. No studies reported medium- or long-term outcomes. Study quality varied, with concerns regarding allocation concealment and selective outcome reporting. Four trials were prospectively registered.

Conclusion
Vitamin D supplementation may reduce short-term pain in PDN, but evidence is limited by small sample sizes and methodological quality. Larger, rigorously designed RCTs with longer follow-up are needed before routine vitamin D testing or supplementation can be recommended for PDN in clinical practice.
Original languageEnglish
Article numbere70118
Number of pages14
JournalEndocrinology, Diabetes & Metabolism
Volume8
Issue number6
Early online date26 Oct 2025
DOIs
Publication statusPublished - 1 Nov 2025

Bibliographical note

Publisher copyright:
© 2025 The Author(s). Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Vitamin D for Painful Diabetic Neuropathy: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials'. Together they form a unique fingerprint.

Cite this